Burzynski Research Institute BZYR
OTC BZYR
$0.01 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Burzynski Research Institute (BZYR) Retained Earnings (2011 - 2025)

Burzynski Research Institute (BZYR) posted Retained Earnings of -$130.5 million for Q4 2025, little changed sequentially from -$130.1 million in Q3 2025, and down 1.0% YoY from -$131.8 million in Q4 2024.

Burzynski Research Institute (BZYR) Retained Earnings (2011 - 2025) Analysis & Trends

Burzynski Research Institute has reported Retained Earnings for 15 years, with the latest figure at -$130.5 million in Q4 2025.

  • Quarterly Retained Earnings fell 1.0% year-over-year to -$130.5 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was -$130.5 million (down 1.0% YoY) and the FY2025 annual result came in at -$129.5 million, down 1.08% from the prior year.
  • Retained Earnings was little changed at -$130.5 million in Q4 2025 per BZYR's latest filing, from -$130.1 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$124.9 million in Q1 2021 and troughed at -$130.5 million in Q4 2025.
  • A 5-year average of -$127.5 million and a median of -$127.2 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2022 and 2024: Retained Earnings slipped 0.69% in 2022, then retreated 1.21% in 2024.
  • Over 5 years, Retained Earnings stood at -$125.7 million in 2021, then fell by 0.69% to -$126.5 million in 2022, then decreased by 0.94% to -$127.7 million in 2023, then dropped by 1.14% to -$129.2 million in 2024, then fell by 1.0% to -$130.5 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$130.5 million, -$130.1 million, and -$129.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.10 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.05 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -6.33 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 20.91 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.57 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 4.38 Bn
10 Burzynski Research Institute 1.31 Mn 1.31 Mn - -130.47 Mn

Historic Data

Download Data
DateValue
Nov 30, 2025 -130.47 Mn
Aug 31, 2025 -130.14 Mn
May 31, 2025 -129.81 Mn
Feb 28, 2025 -129.48 Mn
Nov 30, 2024 -129.18 Mn
Aug 31, 2024 -128.83 Mn
May 31, 2024 -128.46 Mn
Feb 29, 2024 -128.09 Mn
Nov 30, 2023 -127.73 Mn
Aug 31, 2023 -127.29 Mn
May 31, 2023 -127.04 Mn
Feb 28, 2023 -126.75 Mn
Nov 30, 2022 -126.54 Mn
Aug 31, 2022 -126.29 Mn
May 31, 2022 -126.07 Mn
Feb 28, 2022 -125.84 Mn
Nov 30, 2021 -125.67 Mn
Aug 31, 2021 -125.40 Mn
May 31, 2021 -125.18 Mn
Feb 28, 2021 -124.86 Mn